>
网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
干细胞移植治疗肝硬化Meta分析
作者:郭健  陈洪  王智 
单位:东南大学附属中大医院消化科, 江苏 南京 210009
关键词:干细胞移植 肝硬化 随机对照试验 Meta分析 
分类号:R572.2;R457.7
出版年·卷·期(页码):2013·32·第四期(429-436)
摘要:

目的: 通过Meta分析探讨干细胞移植对肝硬化失代偿期的治疗作用。方法: 计算机联合检索中国生物医学文献数据库、万方数据库、CNKI、 PUBMED、EMBASE、Cochrane图书馆、SSCI、VIP获得相关文献,检索时间从建库到2012年5月。对同质研究用RevMan 4.2软件进行Meta分析。结果: 经过排除和筛选,共纳入7篇随机对照实验用于临床评价,共617例患者。干细胞移植术后1、2、3个月肝硬化患者的丙氨酸氨基转移酶(ALT)、天门冬氨酸氨基转移酶(AST)、凝血酶原时间(PT)均较术前有显著下降,血清白蛋白水平(ALB)较术前有显著提高,术后2个月总胆红素(TB)较术前有显著下降,差异均有统计学意义。结论: 骨髓干细胞移植后,患者肝功能改善明显。

Objective: To evaluate the treatment effect of stem cell transplantion for liver cirrhosis by Meta-analysis. Methods: The Cochrance Central Register of Controlled Trials,CBM,CNKI,PUBMED,EMBASE,SSCI,VIP were researched dated up to May 2012.Meta-analysis was performed for homogeneous studies with RevMan 4.2 software. Results: A total of 7 studies carried out by randomization method including 617 patients. we could see the significant decline on the results of ALT,AST,PT obtained from the patients of liver cirrhosis who accepted the stem cell transplantation at 1,2,3 month post operation respectively and the decline on the result of TB at 2 month post operation.Meantime,the result of ALB increased dramatically as well.All the difference was statistically significant. Conclusion: Stem cell transplantation can significantly improve the liver function of patients with good safety and effectiveness.

参考文献:

[1] VERHAGEN A P,HENICA C W,ROBERT A,et al.Acriteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus[J].J Clin Epidemiol,1998,51(12):1235-1241.
[2] LIU M,ZHANG S H.Intention to treat analysis in clinical trials[J].BM J(Chinses edition),2001,4(4):223-224.
[3] 尚建中,赵秋芳,赵林,等.自体骨髓干细胞移植治疗肝硬化失代偿临床研究[J].世界最新医学信息文摘,2012,12(5):5-8.
[4] 焦建中,周小平,李晓云,等.自体骨髓干细胞移植治疗肝硬化失代偿的临床研究[J].西北国防医学杂志,2010,31(3):187-189.
[5] 潘兴南,沈建坤,庄岳,等.自体骨髓干细胞移植治疗终末期肝病临床研究[J].南方医科大学学报,2008,28(7):1207-1209.
[6] 黄茂涛,季代金,冯早明,等.经肝动脉自体骨髓干细胞移植治疗失代偿期肝硬化[J].实用医学杂志,2010,26(17):3166-3168.
[7] 张善红,姜春萌,李荣宽,等.自体骨髓干细胞移植治疗失代偿期肝硬化的临床研究[J].中华临床医师杂志,2012,6(4):1016-1018.
[8] 刘卫,王教学,王丽娟,等.自体骨髓干细胞移植治疗失代偿期肝硬化[J].中华消化外科杂志,2010,9(5):361-363.
[9] 赵和平,丁保华,邵丹,等.自体骨髓干细胞移植治疗失代偿期肝硬化患者的疗效观察[J].实用肝脏病杂志,2011,14(6):424-426.
[10] 孙启芳.外院指导对肝硬化合并上消化道出血患者康复的探讨[J].现代医学,2012,40(6):700-702.
[11] 钱林,胡小宣,陈海鸥,等.脐血干细胞移植治疗失代偿期肝硬化[J].现代医学,2012,40(6):676-678.
[12] 钟文昭,吴一龙,谷力加,等.Revman Manager(RevMen)——临床医生通向Meta分析的桥梁[J].循证医学,2003,3(4):234-246.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 411500 位访问者


copyright ©《东南大学学报(医学版)》编辑部
联系电话:025-83272481 83272483
电子邮件:
bjb@pub.seu.edu.cn

苏ICP备09058364